Navigation Links
Yongye International to Present at the 22nd Roth OC Growth Stock Conference
Date:3/11/2010

BEIJING, March 11 /PRNewswire-Asia-FirstCall/ -- Yongye International, Inc. (Nasdaq: YONG), ("Yongye" or the "Company") a leading developer, manufacturer, and distributor of Shengmingsu brand plant and animal nutrient products in the People's Republic of China (PRC), today announced that the Company's management will present at the upcoming 22nd Annual Roth OC Growth Stock Conference in Laguna Niguel, CA.

    The date, time, and location of Yongye's presentation at the Conference
are as follows:

    Date:          March 16, 2010
    Time:          2:30 p.m. - 3:00 p.m. PDT
    Presenter:     Mr. Zishen Wu, Chairman and CEO
                   Mr. Sam Yu, Chief Financial Officer
    Venue:         Track 4, The Ritz Carlton, Laguna Niguel, CA

The 22nd Annual Roth OC Growth Stock Conference will feature management presentations from over 350 small cap public companies (100 of those companies are based in China.) The presenting companies will represent the following sectors: Healthcare (Biotech, Medical Devices and Pharmaceuticals), Media & Internet, Enterprise Software, Gaming, Semiconductors, Global Energy and Industrials and Retail & Consumer. This event is designed to provide investors with a unique chance to gain insight into small- and mid-cap growth companies and is expected to attract 2,500 attendees, including over 1,500 institutional investors. Interested parties and investors may find more information about the conference by contacting conference@roth.com or calling (800) 933-6830.

About Yongye International, Inc.

Yongye International, Inc., headquartered in Beijing, is engaged in the development, manufacturing, distribution and sales of Shengmingsu brand plant and animal nutrient products. The Company's patented and patent pending formulas and proprietary extraction processes allow it to create products that increase crop yields and improve the health of livestock. Its sole operating subsidiary, Inner Mongolia Yongye Nongfeng Biotechnology Co., Ltd., is headquartered in Beijing with major operations located in Inner Mongolia, People's Republic of China. For more information, please visit the Company's website at http://www.yongyeintl.com .

Safe Harbor Statement

This press release contains certain statements that may include "forward-looking statements." All statements other than statements of historical fact included herein are "forward-looking statements." These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including the risk factors discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on the SEC's website ( http://www.sec.gov ). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these risk factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

    For more information, please contact:

    Yongye International, Inc.
     Mr. Larry Gilmore, VP of Corporate Strategy
     Phone: +86-10-8232-8866 x8880
     Email: larry.gilmore@yongyeintl.com

    CCG Investor Relations, Inc.
     Mr. Crocker Coulson, President
     Phone: +1-646-213-1915 (New York)
     Email: crocker.coulson@ccgir.com

     Athan Dounis, Account Manager
     Phone: +1-646-213-1916
     Email: athan.dounis@ccgir.com
     Web:   http://www.ccgirasia.com

SOURCE Yongye International, Inc.

Back to top

RELATED LINKS
http://www.yongyeintl.com

'/>"/>

SOURCE Yongye International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Yongye International to Present at Rodman & Renshaw Annual China Investment Conference
2. International Merchant Advisors to Complete Purchase of Medical Marijuana Company Organic Science, Inc.
3. International Iridoid Research Council Announced
4. Beware of Getting Caught in the Crossfire, Warns MediCare International
5. IntraHealth International Opens Washington, D.C. Office
6. $250,000 Bioactive Beverage Challenge Announced By Tahitian Noni International
7. St. Elizabeth Medical Residents to Present Research at International Meeting
8. New Alzheimers Prevention Efforts, and Non-Drug Treatments, Featured at 25th Conference of Alzheimers Disease International
9. State-of-the Art in Alzheimers Research Featured at 25th Conference of Alzheimers Disease International
10. Lighthouse International Introduces a New, Customizable, Low-Vision Simulator That Shows How the World Looks to People Who Are Visually Impaired
11. International Medical Corps on the Ground in Chile, Following 8.8-Magnitude Earthquake
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying ... opened registration today for its 33rd Annual Issues & Research Conference, March ... The theme of the conference is “Persistent Challenges and New Opportunities: Using Research ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s ... groups, has aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced ... J. Hennessy, Jr said, “CURE Media Group is honored to team up with Upstage ...
(Date:12/8/2016)... ... December 08, 2016 , ... Launching of ... Unified Instance Manager architecture, meeting the needs of multichannel growth and doubling ... unattended auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, administrative ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... surgery as possible. With this in mind, SIGVARIS has created a new line ... clot) during bed rest and provide the benefits of graduated compression when transitioning ...
(Date:12/8/2016)... ... 08, 2016 , ... The Dan Carlisle Agency, an Alabama-owned ... is announcing the launch of a charity drive to raise support and awareness ... and children in Birmingham has grown steadily since the 1980’s, and the Pathways ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... -- IRIDEX Corporation (NASDAQ: IRIX ) today announced ... stock, $0.01 par value (the "Offering" with such shares being ... terms of the Offering will depend on market and other ... no assurance as to whether or when the Offering may ... proceeds it will receive from this offering for working capital ...
(Date:12/8/2016)... 8, 2016 Global Interventional Radiology Market: ... global interventional radiology market analyzes the current and ... an elaborate executive summary, including a market snapshot ... sub-segments. The research is a combination of ... bulk of our research efforts along with information ...
(Date:12/8/2016)... -- Eli Lilly and Company (NYSE: LLY ) ... trial at the 9 th Clinical Trials on ... not meet the primary endpoint in the EXPEDITION3 clinical ... mild dementia due to Alzheimer,s disease (AD), and Lilly ... treatment of mild dementia due to AD. ...
Breaking Medicine Technology: